Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

National Drug Code

Is NDC 17772-0102-15 recalled?

Trokendi XR

Yes — this exact package was recalled

1 FDA recall names the code 17772-0102-15 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.

1 of these recalls is still ongoing.

Active ingredient
topiramate
Strength
TOPIRAMATE 50 mg/1
Form
Capsule, Extended Release · Oral
Labeler
Supernus Pharmaceuticals, Inc.
Type
Human Prescription Drug
Product code
17772-0102

Recalls naming this package

Class III · Low risk

Trokendi XR

Failed dissolution specifications.

Ongoing Dissolution failure Supernus Pharmaceuticals, Inc. NDC 17772-102-30 D-0833-2026
Class II · Moderate risk

Trokendi XR

Superpotent Drug: Failure of assay specifications in the capsule.

Terminated Wrong potency / content Supernus Pharmaceuticals, Inc. NDC 17772-102-15 D-0112-2017

Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.

Other recalled products from this labeler